COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021 Nov 9, 2021
COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360… Nov 9, 2021
COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder Nov 3, 2021
Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of Psilocybin… Nov 3, 2021
